CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Open-market buy 10% owner bought 4,800 shares at $8.39 ($40,272)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.54 ($85,400)
- 4 Open-market buy 10% owner bought 102,295 shares at an average $8.48 ($867,760)
- 4 Open-market buy 10% owner bought 46,600 shares at $8.61 ($401,226)
- 4 Open-market buy 10% owner bought 3,400 shares at $8.73 ($29,682)
- 4 Open-market buy 10% owner bought 154,003 shares at an average $8.75 ($1,347,925)
- 4 Open-market sale Chief Operating & Med. Officer sold 4,000 shares at $8.90 ($35,600)
- 4 Open-market buy 10% owner bought 2,000 shares at $8.64 ($17,280)
- 4 Open-market buy 10% owner bought 4,043 shares at an average $8.64 ($34,928)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.60 ($86,000)
- 4 Open-market sale Chief Operating & Med. Officer sold 4,000 shares at $9.13 ($36,520)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.55 ($85,500)
- 4 Open-market sale President and CEO sold 35,000 shares at $8.55 ($299,250)
- 4 Open-market sale Chief Operating & Med. Officer sold 4,000 shares at $8.59 ($34,360)
- 4 Gift Chief Financial Officer gave 4,000 shares (gift)
- 4/A Open-market buy 10% owner bought 0 shares
- 4 Open-market buy 10% owner bought 67,700 shares at $17.89 ($1,211,153)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 24 of 30 · 591 filings